Later, other researchers found that PS enhanced PD‐L1 signaling and that the PS‐TAM receptor–PD‐L1–PI3K/ Akt signaling axis may promote tumor immune escape and chemotherapy resistance (Kasikara et al. 2017). The gene discussed is AKT1; the disease is neoplasm.